Skip to main content
Top
Published in: Journal of Neurology 4/2018

01-04-2018 | Short Commentary

Cervical dystonia and substance abuse

Authors: Abhimanyu Mahajan, Joseph Jankovic, Laura Marsh, Achint Patel, H. A. Jinnah, Cynthia Comella, Richard Barbano, Joel Perlmutter, Neepa Patel, For the members of the Dystonia Coalition

Published in: Journal of Neurology | Issue 4/2018

Login to get access

Abstract

Objective

To investigate the prevalence of substance abuse (SA) in patients with cervical dystonia (CD) and to correlate it with prevalence of psychiatric disorders.

Methods

Data on anxiety, depression, dystonia severity, and substance abuse were collected from ten sites participating in the Dystonia Coalition. Patients were divided into two groups according to the presence of SA, utilizing Structured Clinical Interview for DSM-4 criteria. Wilcoxon Rank-Sum test was used to analyze the difference in median scores on the questionnaires between the groups. Chi-square test was used to analyze association between opiate and benzodiazepine use and SA. Association between TWSTRS severity and SA and medication use was assessed. A two-tailed p value of < 0.05 was considered significant. SAS 9.3 (SAS Institute Inc., Cary, NC, USA) was used for all analyses.

Results

Of 208 CD patients, 23 (11%) were identified with SA; 26.3% of patients with SA were on opiates compared to 7.2% of CD patients without SA (p = 0.006). Compared to non-SA patients, those experiencing SA were more likely male (88.9%; p = 0.0007), younger (median age 55; p = 0.031), and scored worse on questionnaires assessing depression (p = 0.044, p = 0.005), anxiety (p = 0.003), and dystonia psychiatric severity (p = 0.033). The median TWSTRS motor severity scores were higher in SA patients compared to non-SA patients (20 versus 16, p = 0.0339). The median TWSTRS total disability, motor, and pain scores were higher in patients on opiates than patients who were not (12 versus 8, p = 0.0071; 18.5 versus 16, p = 0.0243; 12.4 versus 6.7, p = 0.0052, respectively).

Conclusions

Potential risk factors for SA in CD patients include younger age and male gender with comorbid anxiety, depression and other psychiatric problems. Caution should be exercised when prescribing drugs with potential for abuse in these patients.
Literature
3.
go back to reference Tomic S, Petkovic I, Pucic T, Resan B, Juric S, Rotim T (2016) Cervical dystonia and quality of life. Acta Neurol Belg 116(4):589–592CrossRefPubMed Tomic S, Petkovic I, Pucic T, Resan B, Juric S, Rotim T (2016) Cervical dystonia and quality of life. Acta Neurol Belg 116(4):589–592CrossRefPubMed
4.
5.
go back to reference Berardelli I, Ferrazzano G, Pasquini M, Biondi M, Berardelli A, Fabbrini G (2015) Clinical course of psychiatric disorders in patients with cervical dystonia. Psychiatry Res 229(1–2):583–585CrossRefPubMed Berardelli I, Ferrazzano G, Pasquini M, Biondi M, Berardelli A, Fabbrini G (2015) Clinical course of psychiatric disorders in patients with cervical dystonia. Psychiatry Res 229(1–2):583–585CrossRefPubMed
6.
go back to reference Fabbrini G, Berardelli I, Moretti G et al (2010) Psychiatric disorders in adult-onset focal dystonia: a case-control study. Mov Disord 25(4):459–465CrossRefPubMed Fabbrini G, Berardelli I, Moretti G et al (2010) Psychiatric disorders in adult-onset focal dystonia: a case-control study. Mov Disord 25(4):459–465CrossRefPubMed
7.
go back to reference Zurowski M, McDonald WM, Fox S, Marsh L (2013) Psychiatric comorbidities in dystonia: emerging concepts. Mov Disord 28(7):914–920CrossRefPubMed Zurowski M, McDonald WM, Fox S, Marsh L (2013) Psychiatric comorbidities in dystonia: emerging concepts. Mov Disord 28(7):914–920CrossRefPubMed
10.
go back to reference Pirio Richardson S, Wegele AR, Skipper B, Deligtisch A, Jinnah HA (2017) Dystonia treatment: patterns of medication use in an international cohort. Neurology 88(6):543–550CrossRefPubMedPubMedCentral Pirio Richardson S, Wegele AR, Skipper B, Deligtisch A, Jinnah HA (2017) Dystonia treatment: patterns of medication use in an international cohort. Neurology 88(6):543–550CrossRefPubMedPubMedCentral
11.
go back to reference Hasin DS, O’Brien CP, Auriacombe M et al (2013) DSM-5 criteria for substance use disorders: recommendations and rationale. Am J Psychiatry 170(8):834–851CrossRefPubMedPubMedCentral Hasin DS, O’Brien CP, Auriacombe M et al (2013) DSM-5 criteria for substance use disorders: recommendations and rationale. Am J Psychiatry 170(8):834–851CrossRefPubMedPubMedCentral
13.
go back to reference Swendsen J, Conway KP, Degenhardt L et al (2010) Mental disorders as risk factors for substance use, abuse and dependence: results from the 10-year follow-up of the National Comorbidity Survey. Addiction 105(6):1117–1128CrossRefPubMedPubMedCentral Swendsen J, Conway KP, Degenhardt L et al (2010) Mental disorders as risk factors for substance use, abuse and dependence: results from the 10-year follow-up of the National Comorbidity Survey. Addiction 105(6):1117–1128CrossRefPubMedPubMedCentral
14.
go back to reference Compton WM, Thomas YF, Stinson FS, Grant BF (2007) Prevalence, correlates, disability, and comorbidity of DSM-IV drug abuse and dependence in the United States: results from the national epidemiologic survey on alcohol and related conditions. Arch Gen Psychiatry 64(5):566–576CrossRefPubMed Compton WM, Thomas YF, Stinson FS, Grant BF (2007) Prevalence, correlates, disability, and comorbidity of DSM-IV drug abuse and dependence in the United States: results from the national epidemiologic survey on alcohol and related conditions. Arch Gen Psychiatry 64(5):566–576CrossRefPubMed
15.
go back to reference Kessler RC, Berglund P, Demler O, Jin R, Merikangas KR, Walters EE (2005) Lifetime prevalence and age-of-onset distributions of DSM-IV disorders in the National Comorbidity Survey Replication. Arch Gen Psychiatry 62(6):593–602CrossRefPubMed Kessler RC, Berglund P, Demler O, Jin R, Merikangas KR, Walters EE (2005) Lifetime prevalence and age-of-onset distributions of DSM-IV disorders in the National Comorbidity Survey Replication. Arch Gen Psychiatry 62(6):593–602CrossRefPubMed
17.
go back to reference Regier DA, Farmer ME, Rae DS et al (1990) Comorbidity of mental disorders with alcohol and other drug abuse. Results from the Epidemiologic Catchment Area (ECA) Study. JAMA 264(19):2511–2518CrossRefPubMed Regier DA, Farmer ME, Rae DS et al (1990) Comorbidity of mental disorders with alcohol and other drug abuse. Results from the Epidemiologic Catchment Area (ECA) Study. JAMA 264(19):2511–2518CrossRefPubMed
18.
go back to reference Bruce SE, Yonkers KA, Otto MW et al (2005) Influence of psychiatric comorbidity on recovery and recurrence in generalized anxiety disorder, social phobia, and panic disorder: a 12-year prospective study. Am J Psychiatry 162(6):1179–1187CrossRefPubMedPubMedCentral Bruce SE, Yonkers KA, Otto MW et al (2005) Influence of psychiatric comorbidity on recovery and recurrence in generalized anxiety disorder, social phobia, and panic disorder: a 12-year prospective study. Am J Psychiatry 162(6):1179–1187CrossRefPubMedPubMedCentral
19.
go back to reference Kyllerman M, Forsgren L, Sanner G, Holmgren G, Wahlstrom J, Drugge U (1990) Alcohol-responsive myoclonic dystonia in a large family: dominant inheritance and phenotypic variation. Mov Disord 5(4):270–279CrossRefPubMed Kyllerman M, Forsgren L, Sanner G, Holmgren G, Wahlstrom J, Drugge U (1990) Alcohol-responsive myoclonic dystonia in a large family: dominant inheritance and phenotypic variation. Mov Disord 5(4):270–279CrossRefPubMed
21.
go back to reference Hall AJ, Logan JE, Toblin RL et al (2008) Patterns of abuse among unintentional pharmaceutical overdose fatalities. JAMA 300(22):2613–2620CrossRefPubMed Hall AJ, Logan JE, Toblin RL et al (2008) Patterns of abuse among unintentional pharmaceutical overdose fatalities. JAMA 300(22):2613–2620CrossRefPubMed
22.
go back to reference Edlund MJ, Sullivan M, Steffick D, Harris KM, Wells KB (2007) Do users of regularly prescribed opioids have higher rates of substance use problems than nonusers? Pain Med 8(8):647–656CrossRefPubMed Edlund MJ, Sullivan M, Steffick D, Harris KM, Wells KB (2007) Do users of regularly prescribed opioids have higher rates of substance use problems than nonusers? Pain Med 8(8):647–656CrossRefPubMed
23.
go back to reference Forman RF, Svikis D, Montoya ID, Blaine J (2004) Selection of a substance use disorder diagnostic instrument by the National Drug Abuse Treatment Clinical Trials Network. J Subst Abuse Treat 27(1):1–8CrossRefPubMedPubMedCentral Forman RF, Svikis D, Montoya ID, Blaine J (2004) Selection of a substance use disorder diagnostic instrument by the National Drug Abuse Treatment Clinical Trials Network. J Subst Abuse Treat 27(1):1–8CrossRefPubMedPubMedCentral
24.
go back to reference van den Dool J, Tijssen MA, Koelman JH, Engelbert RH, Visser B (2016) Determinants of disability in cervical dystonia. Parkinsonism Relat Disord 32:48–53CrossRefPubMed van den Dool J, Tijssen MA, Koelman JH, Engelbert RH, Visser B (2016) Determinants of disability in cervical dystonia. Parkinsonism Relat Disord 32:48–53CrossRefPubMed
25.
go back to reference Landsman-Blumberg PB, Katz N, Gajria K, Coutinho AD, Yeung PP, White R (2017) Burden of alcohol abuse or dependence among long-term opioid users with chronic noncancer pain. J Manag Care Spec Pharm 23(7):718–724CrossRefPubMed Landsman-Blumberg PB, Katz N, Gajria K, Coutinho AD, Yeung PP, White R (2017) Burden of alcohol abuse or dependence among long-term opioid users with chronic noncancer pain. J Manag Care Spec Pharm 23(7):718–724CrossRefPubMed
Metadata
Title
Cervical dystonia and substance abuse
Authors
Abhimanyu Mahajan
Joseph Jankovic
Laura Marsh
Achint Patel
H. A. Jinnah
Cynthia Comella
Richard Barbano
Joel Perlmutter
Neepa Patel
For the members of the Dystonia Coalition
Publication date
01-04-2018
Publisher
Springer Berlin Heidelberg
Published in
Journal of Neurology / Issue 4/2018
Print ISSN: 0340-5354
Electronic ISSN: 1432-1459
DOI
https://doi.org/10.1007/s00415-018-8840-9

Other articles of this Issue 4/2018

Journal of Neurology 4/2018 Go to the issue